Insider · CIK 0001815111
Roderick H. MacLeod
cfoofficer
Files at NVRO (NEVRO CORP). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | NVRO NEVRO CORP | DDisposition to issuer Common Stock | -350,663 | - | - | 0 | Apr 3, 2025 |
| Dec 7, 2024 | NVRO NEVRO CORP | FTax withholding Common Stock | -1,759 | $4.19 | $7,370 | 131,359 | Dec 9, 2024 |
| Nov 28, 2024 | NVRO NEVRO CORP | FTax withholding Common Stock | -816 | $4.58 | $3,737 | 133,118 | Dec 2, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.